Diabetes Care, Vol 22, Issue 1 45-49, Copyright © 1999 by American Diabetes Association

ARTICLES

Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men

JV Bjornholt, G Erikssen, E Aaser, L Sandvik, S Nitter-Hauge, J Jervell, J Erikssen and E Thaulow
Medical Department, Rikshospitalet, Oslo, Norway.

OBJECTIVE: Because of the available conflicting epidemiological data, we investigated the possible impact of fasting blood glucose as a risk factor for cardiovascular death in nondiabetic men. This study reports the results from a 22-year prospective study on fasting blood glucose as a predictor of cardiovascular death. RESEARCH DESIGN AND METHODS: Of the 1,998 apparently healthy nondiabetic men (aged 40-59 years), a total of 1,973 with fasting blood glucose < 110 mg/dl were included in the study in which also a number of conventional risk factors were measured at baseline. RESULTS: After 22 years of follow-up, 483 men had died, 53% from cardiovascular diseases. After dividing men into quartiles of fasting blood glucose level, it was found that men in the highest glucose quartile (fasting blood glucose > 85 mg/dl) had a significantly higher mortality rate from cardiovascular diseases compared with those in the three lowest quartiles. Even after adjusting for age, smoking habits, serum lipids, blood pressure, forced expiratory volume in 1 s, and physical fitness (Cox model), the relative risk of cardiovascular death for men with fasting blood glucose > 85 mg/dl remained 1.4 (95% CI 1.04-1.8). Noncardiovascular deaths were unrelated to fasting blood glucose level. CONCLUSIONS: Fasting blood glucose values in the upper normal range appears to be an important independent predictor of cardiovascular death in nondiabetic apparently healthy middle-aged men.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Delgado, J. M. Diaz, I. Silva, J. M. Osorio, A. Osuna, B. Bayes, R. Lauzurica, E. Arellano, J. M. Campistol, R. Dominguez, et al. Unmasking Glucose Metabolism Alterations in Stable Renal Transplant Recipients: A Multicenter Study Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 808 - 813. [Abstract] [Full Text] [PDF]

				A. L. Berends, C. J.M. de Groot, E. J. Sijbrands, M. P.S. Sie, S. H. Benneheij, R. Pal, R. Heydanus, B. A. Oostra, C. M. van Duijn, and E. A.P. Steegers Shared Constitutional Risks for Maternal Vascular-Related Pregnancy Complications and Future Cardiovascular Disease Hypertension, April 1, 2008; 51(4): 1034 - 1041. [Abstract] [Full Text] [PDF]

				E. L.M. Barr, P. Z. Zimmet, T. A. Welborn, D. Jolley, D. J. Magliano, D. W. Dunstan, A. J. Cameron, T. Dwyer, H. R. Taylor, A. M. Tonkin, et al. Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation, July 10, 2007; 116(2): 151 - 157. [Abstract] [Full Text] [PDF]

				M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]

				O. Cohen, R. Basu, G. Bock, C. Dalla Man, M. Campioni, A. Basu, G. Toffolo, C. Cobelli, and R. A. Rizza Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength Diabetes Care, December 1, 2006; 29(12): 2708 - 2713. [Abstract] [Full Text] [PDF]

				D. Thornley-Brown, X. Wang, J. T. Wright Jr, O. S. Randall, E. R. Miller, J. P. Lash, J. Gassman, G. Contreras, L. J. Appel, L. Y. Agodoa, et al. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. Arch Intern Med, April 10, 2006; 166(7): 797 - 805. [Abstract] [Full Text] [PDF]

				R Otten, E Kline-Rogers, D J Meier, R Dumasia, J Fang, N May, Y Resin, D F Armstrong, F Saab, M Petrina, et al. Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome Heart, November 1, 2005; 91(11): 1466 - 1468. [Full Text] [PDF]

				S. H. Jee, H. Ohrr, J. W. Sull, J. E. Yun, M. Ji, and J. M. Samet Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women JAMA, January 12, 2005; 293(2): 194 - 202. [Abstract] [Full Text] [PDF]

				M. B. Davidson Early Insulin Therapy for Type 2 Diabetic Patients: More Cost Than Benefit Diabetes Care, January 1, 2005; 28(1): 222 - 224. [Full Text] [PDF]

				Asia Pacific Cohort Studies Collaboration Blood Glucose and Risk of Cardiovascular Disease in the Asia Pacific Region Diabetes Care, December 1, 2004; 27(12): 2836 - 2842. [Abstract] [Full Text] [PDF]

				M. Bartnik, K. Malmberg, A. Norhammar, A. Tenerz, J. Ohrvik, and L. Ryden Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction Eur. Heart J., November 2, 2004; 25(22): 1990 - 1997. [Abstract] [Full Text] [PDF]

				E. B. Levitan, Y. Song, E. S. Ford, and S. Liu Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?: A Meta-analysis of Prospective Studies Arch Intern Med, October 25, 2004; 164(19): 2147 - 2155. [Abstract] [Full Text] [PDF]

				M.-E. Piche, J.-F. Arcand-Bosse, J.-P. Despres, L. Perusse, S. Lemieux, and S. J. Weisnagel What is a Normal Glucose Value?: Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose Diabetes Care, October 1, 2004; 27(10): 2470 - 2477. [Abstract] [Full Text] [PDF]

				D. Tanne, N. Koren-Morag, and U. Goldbourt Fasting Plasma Glucose and Risk of Incident Ischemic Stroke or Transient Ischemic Attacks: A Prospective Cohort Study Stroke, October 1, 2004; 35(10): 2351 - 2355. [Abstract] [Full Text] [PDF]

				N. M. Punjabi, E. Shahar, S. Redline, D. J. Gottlieb, R. Givelber, and H. E. Resnick Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health Study Am. J. Epidemiol., September 15, 2004; 160(6): 521 - 530. [Abstract] [Full Text] [PDF]

				G. Erikssen, J. Bodegard, J. V. Bjornholt, K. Liestol, D. S. Thelle, and J. Erikssen Exercise testing of healthy men in a new perspective: from diagnosis to prognosis Eur. Heart J., June 1, 2004; 25(11): 978 - 986. [Abstract] [Full Text] [PDF]

				R. S. Fries, P. Mahboubi, N. R. Mahapatra, S. K. Mahata, N. J. Schork, G. W. Schmid-Schoenbein, and D. T. O'Connor Neuroendocrine Transcriptome in Genetic Hypertension: Multiple Changes in Diverse Adrenal Physiological Systems Hypertension, June 1, 2004; 43(6): 1301 - 1311. [Abstract] [Full Text] [PDF]

				G. J. Blake, A. D. Pradhan, J. E. Manson, G. R. Williams, J. Buring, P. M. Ridker, and R. J. Glynn Hemoglobin A1c Level and Future Cardiovascular Events Among Women Arch Intern Med, April 12, 2004; 164(7): 757 - 761. [Abstract] [Full Text] [PDF]

				Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]

				Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]

				Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2004; 27(90001): s47 - 47. [Full Text] [PDF]

				The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]

				J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]

				R. Harris, K. Donahue, S. S. Rathore, P. Frame, S. H. Woolf, and K. N. Lohr Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, February 4, 2003; 138(3): 215 - 229. [Abstract] [Full Text] [PDF]

				S. I. McFarlane and J. R. Sowers Aldosterone Function in Diabetes Mellitus: Effects on Cardiovascular and Renal Disease J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 516 - 523. [Full Text] [PDF]

				H. C. Gerstein, S. Anand, Q. L. Yi, V. Vuksan, E. Lonn, K. Teo, K. Malmberg, M. McQueen, and S. Yusuf The Relationship Between Dysglycemia and Atherosclerosis in South Asian, Chinese, and European Individuals in Canada: A randomly sampled cross-sectional study Diabetes Care, January 1, 2003; 26(1): 144 - 149. [Abstract] [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2003; 26(90001): s62 - 69. [Full Text] [PDF]

				J Sala, R Masia, F-J Gonzalez de Molina, J M Fernandez-Real, M Gil, D Bosch, W Ricart, M Senti, and J Marrugat Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission J Epidemiol Community Health, September 1, 2002; 56(9): 707 - 712. [Abstract] [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Clin. Diabetes, July 1, 2002; 20(3): 109 - 116. [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Spectr, July 1, 2002; 15(3): 147 - 157. [Full Text] [PDF]

				R. S. Surwit, R. B. Williams, I. C. Siegler, J. D. Lane, M. Helms, K. L. Applegate, N. Zucker, M. N. Feinglos, C. M. McCaskill, and J. C. Barefoot Hostility, Race, and Glucose Metabolism in Nondiabetic Individuals Diabetes Care, May 1, 2002; 25(5): 835 - 839. [Abstract] [Full Text] [PDF]

				American Diabetes Association The Prevention or Delay of Type 2 Diabetes Diabetes Care, April 1, 2002; 25(4): 742 - 749. [Full Text] [PDF]

				J. Hjelmesath, A. Hartmann, K. Midtvedt, S. Aakhus, J. Stenstrom, L. Morkrid, T. Egeland, H. Tordarson, and P. Fauchald Metabolic cardiovascular syndrome after renal transplantation Nephrol. Dial. Transplant., May 1, 2001; 16(5): 1047 - 1052. [Abstract] [Full Text] [PDF]

				A. Pascot, J.-P. Després, I. Lemieux, N. Alméras, J. Bergeron, A. Nadeau, D. Prud’homme, A. Tremblay, and S. Lemieux Deterioration of the Metabolic Risk Profile in Women: Respective contributions of impaired glucose tolerance and visceral fat accumulation Diabetes Care, May 1, 2001; 24(5): 902 - 908. [Abstract] [Full Text]

				X.-H. Zhang, D. Lowe, P. Giles, S. Fell, M. J. Connock, and D. J. Maslin Gender May Affect the Action of Garlic Oil on Plasma Cholesterol and Glucose Levels of Normal Subjects J. Nutr., May 1, 2001; 131(5): 1471 - 1478. [Abstract] [Full Text]

				M. B. Davidson How Do We Diagnose Diabetes and Measure Blood Glucose Control?: View 1: (Diagnosing) A Clinical Basis for the Diagnosis of Diabetes Diabetes Spectr, April 1, 2001; 14(2): 67 - 71. [Abstract] [Full Text] [PDF]

				DECODE Study Group; on behalf of the European Diab Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria Arch Intern Med, February 12, 2001; 161(3): 397 - 405. [Abstract] [Full Text] [PDF]

				G Erikssen, K Liestol, J.V Bjornholt, H Stormorken, E Thaulow, and J Erikssen Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality Eur. Heart J., October 1, 2000; 21(19): 1614 - 1620. [Abstract] [PDF]

				V. Vuksan, M. P Stavro, J. L Sievenpiper, V. Y. Koo, E. Wong, U. Beljan-Zdravkovic, T. Francis, A. L Jenkins, L. A Leiter, R. G Josse, et al. American Ginseng Improves Glycemia in Individuals with Normal Glucose Tolerance: Effect of Dose and Time Escalation J. Am. Coll. Nutr., June 1, 2000; 19(6): 738 - 744. [Abstract] [Full Text] [PDF]

				M. Wei, L. W. Gibbons, T. L. Mitchell, J. B. Kampert, M. P. Stern, and S. N. Blair Low Fasting Plasma Glucose Level as a Predictor of Cardiovascular Disease and All-Cause Mortality Circulation, May 2, 2000; 101(17): 2047 - 2052. [Abstract] [Full Text] [PDF]